Q&As on Annual Reports

Questions and Answers on Listed Companies Annual Reports Singapore
Sort By: Company Name: Market:
Array
(
    [0] => WP_Post Object
        (
            [ID] => 5477
            [post_author] => 26
            [post_date] => 2018-10-03 17:09:56
            [post_date_gmt] => 2018-10-03 09:09:56
            [post_content] => 
            [post_title] => iX Biopharma Ltd
            [post_excerpt] => 
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => ix-biopharma-ltd-3
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-05-28 12:32:12
            [post_modified_gmt] => 2019-05-28 04:32:12
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://sias.org.sg/?post_type=annual_reports&p=5477
            [menu_order] => 0
            [post_type] => annual_reports
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [1] => WP_Post Object
        (
            [ID] => 4361
            [post_author] => 1
            [post_date] => 2018-07-26 19:42:19
            [post_date_gmt] => 2018-07-26 11:42:19
            [post_content] => 
            [post_title] => iX Biopharma Ltd
            [post_excerpt] => 
            [post_status] => publish
            [comment_status] => open
            [ping_status] => open
            [post_password] => 
            [post_name] => ix-biopharma-ltd-2
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2018-08-14 16:22:19
            [post_modified_gmt] => 2018-08-14 08:22:19
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => http://sias2017.php-dp.com/annual_reports/ix-biopharma-ltd-2/
            [menu_order] => 0
            [post_type] => annual_reports
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [2] => WP_Post Object
        (
            [ID] => 4129
            [post_author] => 1
            [post_date] => 2018-07-26 19:40:39
            [post_date_gmt] => 2018-07-26 11:40:39
            [post_content] => 
            [post_title] => iX Biopharma Ltd
            [post_excerpt] => 
            [post_status] => publish
            [comment_status] => open
            [ping_status] => open
            [post_password] => 
            [post_name] => ix-biopharma-ltd
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2018-08-14 16:22:14
            [post_modified_gmt] => 2018-08-14 08:22:14
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => http://sias2017.php-dp.com/annual_reports/ix-biopharma-ltd/
            [menu_order] => 0
            [post_type] => annual_reports
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

)
Array
(
    [company] => iX Biopharma Ltd
    [cid] => 5477,4361,4129
)
Array
(
    [post_type] => annual_reports
    [showposts] => -1
    [meta_key] => agm_date
    [orderby] => Array
        (
            [meta_value] => DESC
            [title] => ASC
        )

    [order] => DESC
    [paged] => 1
    [post_title_like] => iX Biopharma Ltd
    [meta_query] => Array
        (
            [key] => mark_as_upcoming_qa
            [value] => 
            [compare] => =
        )

)
Array
(
    [0] => WP_Post Object
        (
            [ID] => 5477
            [post_author] => 26
            [post_date] => 2018-10-03 17:09:56
            [post_date_gmt] => 2018-10-03 09:09:56
            [post_content] => 
            [post_title] => iX Biopharma Ltd
            [post_excerpt] => 
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => ix-biopharma-ltd-3
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2019-05-28 12:32:12
            [post_modified_gmt] => 2019-05-28 04:32:12
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://sias.org.sg/?post_type=annual_reports&p=5477
            [menu_order] => 0
            [post_type] => annual_reports
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [1] => WP_Post Object
        (
            [ID] => 4361
            [post_author] => 1
            [post_date] => 2018-07-26 19:42:19
            [post_date_gmt] => 2018-07-26 11:42:19
            [post_content] => 
            [post_title] => iX Biopharma Ltd
            [post_excerpt] => 
            [post_status] => publish
            [comment_status] => open
            [ping_status] => open
            [post_password] => 
            [post_name] => ix-biopharma-ltd-2
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2018-08-14 16:22:19
            [post_modified_gmt] => 2018-08-14 08:22:19
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => http://sias2017.php-dp.com/annual_reports/ix-biopharma-ltd-2/
            [menu_order] => 0
            [post_type] => annual_reports
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [2] => WP_Post Object
        (
            [ID] => 4129
            [post_author] => 1
            [post_date] => 2018-07-26 19:40:39
            [post_date_gmt] => 2018-07-26 11:40:39
            [post_content] => 
            [post_title] => iX Biopharma Ltd
            [post_excerpt] => 
            [post_status] => publish
            [comment_status] => open
            [ping_status] => open
            [post_password] => 
            [post_name] => ix-biopharma-ltd
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2018-08-14 16:22:14
            [post_modified_gmt] => 2018-08-14 08:22:14
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => http://sias2017.php-dp.com/annual_reports/ix-biopharma-ltd/
            [menu_order] => 0
            [post_type] => annual_reports
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

)
Array
(
    [company] => iX Biopharma Ltd
    [cid] => 5477,4361,4129
)
Array
(
    [post_type] => annual_reports
    [showposts] => 12
    [meta_key] => agm_date
    [orderby] => Array
        (
            [meta_value] => DESC
            [title] => ASC
        )

    [order] => DESC
    [paged] => 1
    [post_title_like] => iX Biopharma Ltd
    [meta_query] => Array
        (
            [key] => mark_as_upcoming_qa
            [value] => 
            [compare] => =
        )

)
AGM Date Company Market Annual Report SIAS Questions Company Response
AGM Date: 19/10/2018 19/10/2018 Company: iX Biopharma Ltd iX Biopharma Ltd Market: Catalist Catalist Annual Report: Download Download SIAS Questions1. Can management help shareholders understand the R&D budget set aside... Read More
AGM Date: 24/10/2017 24/10/2017 Company: iX Biopharma Ltd iX Biopharma Ltd Market: Catalist Catalist Annual Report: Download Download SIAS Questions1. The group report a revenue increase of 10% to $6.4 million in 2017... 2. The group has developed a new pipeline of nutraceutical products and... 3. As disclosed in the Corporate Governance Report (page 29), a sum of $130,000... Read More Company Response1. Revenue of Chemical Analysis increased 7% in FY2017 over FY2016. There... 2. We have identified 5 major regions in which we are exploring launching... 3. During FY2017, Centrum Capital had been engaged to provide... Read More
AGM Date: 25/10/2016 25/10/2016 Company: iX Biopharma Ltd iX Biopharma Ltd Market: Catalist Catalist Annual Report: Download Download SIAS Questions1. New drug application is extremely costly and time consuming and shareholders may not be... 2. For the benefit of the current shareholders, the group must manage its expenses and cash... 3. In the Remuneration section in the Corporate Governance report (page 19), the... Read More Company Response1. Product: Wafermine™ Sublingual ketamine; PheoniX™ Sublingual... 2. Excluding share - based compensation, clinical t rials and... 3. RC commissioned Carrots Consulting to review the... Read More


Upcoming Q&A
Adventus Holdings Ltd AEI Corporation Ltd Annica Holdings Ltd
Asian Pay Television Trust Aspial Corporation Ltd Banyan Tree Holdings Ltd
Bonvests Holdings Ltd CDW Holding Ltd CNMC Goldmine Holdings Ltd
Dasin Retail Trust Edition Ltd Global Testing Corporation Ltd
Green Build Technology Ltd HealthBank Holdings Ltd Heeton Holdings Ltd
Hengyang Petrochemical Logistics Ltd Hong Lai Huat Group Ltd Hotel Grand Central Ltd
Interra Resources Ltd Intraco Ltd IPC Corporation Ltd
Jadason Enterprises Ltd Jiutian Chemical Group Ltd Joyas International Holdings Ltd
KTMG Ltd (formerly known as Lereno Bio-Chem Ltd) Leader Environmental Technologies Ltd Matex International Ltd
Mencast Holdings Ltd NauticAWT Ltd Net Pacific Financial Holdings Ltd
Oceanus Group Ltd Olive Tree Estates Ltd Prime US REIT
QT Vascular Ltd REVEZ Corporation Ltd Sevak Ltd (formerly known as S i2i Ltd)
Silkroad Nickel Ltd Southern Packaging Group Ltd Starburst Holdings Ltd
Suntar Eco-City Ltd Tat Seng Packaging Group Ltd Top Global Ltd
Trek 2000 International Ltd Union Gas Holdings Ltd World Precision Machinery Ltd
Y Ventures Group Ltd Yanlord Land Group Ltd YHI International Ltd